Those undergoing cancer treatment find themselves facing the fight of their lives.
And many health experts are eager to discover an effective cancer treatment method that isn't as devastating as radiation and chemo.
Perhaps one of the most known is vitamin B17.
Sloan-Kettering's cancer research facility in New York.
In the 1970s, America's war on cancer was in full swing, and Sloan-Kettering was one of the country's leading cancer research centers.
Ralph Moss joined the center in 1974, just as they were testing Laetrile – a form of vitamin B17.
It was Moss' first big job, and he was right in the midst of a potentially earth-shattering discovery.
But the tides quickly changed as Sloan-Kettering's Board of Directors learned more. Laetrile was swept under the rug, and the research put aside when Laetrile was determined to be potentially harmful.
Ralph Moss couldn't sit on what he saw as B17's potential. He called a press conference on his own and accused his employer of orchestrating a major coverup of B17 research.
Laetrile has since been banned in the United States.
B-17's History
Sloan-Kettering's cancer research facility in New York.
In the 1970s, America's war on cancer was in full swing, and Sloan-Kettering was one of the country's leading cancer research centers.
Ralph Moss joined the center in 1974, just as they were testing Laetrile – a form of vitamin B17.
It was Moss' first big job, and he was right in the midst of a potentially earth-shattering discovery.
But the tides quickly changed as Sloan-Kettering's Board of Directors learned more. Laetrile was swept under the rug, and the research put aside when Laetrile was determined to be potentially harmful.
Ralph Moss couldn't sit on what he saw as B17's potential. He called a press conference on his own and accused his employer of orchestrating a major coverup of B17 research.
Laetrile has since been banned in the United States.